Bank of New York Mellon
BVS icon

Bank of New York Mellon’s Bioventus BVS Stock Holding History

Bank of New York Mellon’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
152,316
+8,407
+6% +$80.3K ﹤0.01% 3147
2026
Q1 		$1.31M Sell
143,909
-6,193
-4% -$51.9K ﹤0.01% 3050
2025
Q4 		$1.12M Buy
150,102
+18,382
+14% +$132K ﹤0.01% 3173
2025
Q3 		$881K Sell
131,720
-3,507
-3% -$24.3K ﹤0.01% 3277
2025
Q2 		$895K Buy
135,227
+15,178
+13% +$108K ﹤0.01% 3193
2025
Q1 		$1.1M Sell
120,049
-5,006
-4% -$50K ﹤0.01% 3015
2024
Q4 		$1.31M Buy
125,055
+34,036
+37% +$403K ﹤0.01% 2977
2024
Q3 		$1.09M Sell
91,019
-21,458
-19% -$186K ﹤0.01% 3093
2024
Q2 		$647K Buy
+112,477
New +$617K ﹤0.01% 3437
2024
Q1 		– Sell
-15,042
Closed -$79.3K – 4180
2023
Q4 		$79.3K Sell
15,042
-77,251
-84% -$306K ﹤0.01% 4123
2023
Q3 		$305K Buy
92,293
+3,434
+4% +$12K ﹤0.01% 3791
2023
Q2 		$257K Sell
88,859
-94,334
-51% -$181K ﹤0.01% 3896
2023
Q1 		$196K Sell
183,193
-10,050
-5% -$19.2K ﹤0.01% 3933
2022
Q4 		$504K Sell
193,243
-16,023
-8% -$70K ﹤0.01% 3535
2022
Q3 		$1.47M Buy
209,266
+10,099
+5% +$79.1K ﹤0.01% 3023
2022
Q2 		$1.36M Buy
199,167
+45,460
+30% +$464K ﹤0.01% 3049
2022
Q1 		$2.17M Buy
153,707
+4,382
+3% +$58.7K ﹤0.01% 2885
2021
Q4 		$2.16M Buy
149,325
+90,694
+155% +$1.29M ﹤0.01% 2942
2021
Q3 		$830K Buy
58,631
+41,113
+235% +$633K ﹤0.01% 3504
2021
Q2 		$308K Buy
17,518
+1,417
+9% +$22.8K ﹤0.01% 3957
2021
Q1 		$246K Buy
+16,101
New +$229K ﹤0.01% 3987

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

Bank of New York Mellon's BVS Position: Q2 2026 in Review

Bank of New York Mellon increased its Bioventus (BVS) stake by 5.8% in Q2 2026, buying an estimated $80.3K and bringing the position to 152,316 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

Bank of New York Mellon first reported a position in BVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.17M in Q1 2022. 80 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Bank of New York Mellon held 152,316 shares of Bioventus worth $1.44M as of Q2 2026.
  • Bank of New York Mellon bought 8,407 Bioventus shares in Q2 2026, an estimated $80.3K.
  • Bioventus made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3147 holding.
  • Bank of New York Mellon first reported a position in Bioventus in Q1 2021 and has held it in 21 quarters since.
  • Bank of New York Mellon's Bioventus position peaked at $2.17M in Q1 2022.
  • 80 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.